Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism
Tatsuhiro Shibata(United Cerebral Palsy), Satoshi Yasuda(National Cerebral and Cardiovascular Center), Hisao Ogawa(Jikei University School of Medicine), Shoji Kawakami(National Cerebral and Cardiovascular Center), Kazuhiro Nakao(United Cerebral Palsy), Toshiyuki Nagai(United Cerebral Palsy), Toshihisa Anzai(National Cerebral and Cardiovascular Center), Tomoaki Kanaya(United Cerebral Palsy), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Masashi Fujino(Queen Mary Hospital), Tomotaka Tanaka(Shimane University), Teruo Noguchi(National Cerebral and Cardiovascular Center), Yasuhide Asaumi(National Cerebral and Cardiovascular Center), Kazuyuki Nagatsuka(United Cerebral Palsy), Hatsue Ishibashi‐Ueda(United Cerebral Palsy), Yoshihiro Miyamoto(National Cerebral and Cardiovascular Center), Yoichi Goto(United Cerebral Palsy), Kengo Kusano(National Cerebral and Cardiovascular Center)
Cited by 401
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753